Boruidi Biotechnology
博瑞迪生物
Boruidi Biotechnology (博瑞迪生物) is a Chinese molecular breeding CRO founded in April 2017 by Zhang Jianan, a former millet breeding researcher who spent six years in traditional crop selection before pivoting to develop domestic liquid-phase chip technology for agriculture . The company operates an unmanned intelligent molecular breeding laboratory system that automates DNA extraction, quality control, library construction and sequencing, with annual throughput reaching 2 million samples as of 2023 .
Boruidi's core innovation replaces expensive imported solid-phase chips with self-developed liquid-phase chips, cutting breeding costs by over 90% and shortening qualified germplasm development cycles by more than 50% while improving selection accuracy by 20-30% . The company has built 580-plus liquid-phase chip products covering 200 species across crops, livestock and aquaculture, with cumulative testing exceeding 2 million samples . In 2023 it expanded into bespoke crop variety development as a CRO service—its first custom order, completed in November that year, delivered a multi-resistant, high-yield corn variety in 18 months versus the typical 6-year timeline .
Dalton Venture invested in Boruidi in 2023, describing it at the time as China's largest crop and animal breeding CRO . The company was named a national "Little Giant" enterprise in 2024 and began building overseas testing labs in the Netherlands, UK and US that same year . R&D staff comprise 35% of headcount, with annual R&D spending held at no less than 15% of revenue .
AI-generated — may contain errors, please verify.
Coverage
From Early Innovation to Industry Recognition: A Map of Dalton Venture's Specialized and Innovative Portfolio Companies
"Specialized, refined, distinctive, and innovative" enterprises are increasingly becoming a key benchmark for assessing the growth quality of China's technology and innovation companies. It represents not only a company's technical strength, innovation capability, and growth potential in niche sectors, but also serves as external validation from the industrial system of the value of outstanding SMEs. Recently, **Xuanyu Medical**, a **Dalton Venture family company**, was once again named to **Shanghai's second batch of 2026 specialized, refined, distinctive, and innovative SMEs. This marks Xuanyu Medical's continued recognition following its 2023 selection.
Into the Dalton Family | Biolid: Where Seeds Can Be "Tailor-Made"
A pile of seeds sits before you — which ones will sprout fastest? Which will yield the most? Which will have the best quality? Traditional breeding requires months of careful observation in the field, taking at least three months of "looking, smelling, asking, and examining" to find answers. But at Shijiazhuang Biolid Biotechnology, it takes just 7 to 14 days. How is this possible? Welcome to **Dalton Venture Family company Biolid**, as we explore how Biolid spent eight years breaking foreign technology monopolies to successfully develop liquid-phase chip detection technology, dramatically shortening seed [text cuts off]

